US 8883135
Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor
granted A61KA61K31/496A61K45/06
Quick answer
US patent 8883135 (Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/496, A61K45/06, A61P, A61P31/14